Skip to Content

Minoxidil topical Pregnancy and Breastfeeding Warnings

Minoxidil topical is also known as: Hair Regrowth Treatment for Men, Hair Regrowth Treatment for Women, Rogaine, Rogaine Extra Strength, Rogaine Men's Extra Strength, Rogaine Women's, Ronoxidil

Minoxidil topical Pregnancy Warnings

Minoxidil topical has been assigned to pregnancy category C by the FDA. Animal studies using oral minoxidil have failed to reveal evidence of teratogenicity, but reduced conception rates and an increased incidence of fetal absorption have been observed in rabbits given 5 times the usual human oral dose. Minoxidil topical should not be administered to pregnant women.

Only four cases of exposure to oral minoxidil in human pregnancy have been reported. In two of these four cases, minoxidil was associated with congenital abnormalities, but the presence of severe hypertension and the use of other drugs, including an ACE inhibitor in one case, make implication of minoxidil as a teratogen or as the sole teratogen difficult. Hypertrichosis was markedly evident in one malformed infant and as the sole abnormality in the other. One infant, whose mother was taking oral minoxidil throughout gestation, showed no adverse effects.

See references

Minoxidil topical Breastfeeding Warnings

Limited data from a single study of a woman who was taking oral minoxidil 7.5 mg daily reveals a maximum milk to maternal plasma concentration ratio of 1:3 at one hour after dosing. Minoxidil was also detected in the breast milk of a woman taking minoxidil orally 5 mg twice a day.

Minoxidil is excreted into breast milk. Because of the potential for adverse effects in nursing infants, minoxidil topical should not be used by nursing women.

See references

References for pregnancy information

  1. "PDR Generics." Montvale, NJ: Medical Economics (1995):

References for breastfeeding information

  1. "PDR Generics." Montvale, NJ: Medical Economics (1995):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.